In Licensing
 KLAB can in license and market speciality product to there existing key doctors namely medical oncologists, radiation oncologists, surgical oncologists and hemato oncologists.  


New Facility In Uttaranchal As Per Latest USFDA guidelines. Manufacturing Unit for General Tablets and Cephalosporin tablets with full Excise Duty and Sales Tax benefits. 



Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)


Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

Out Licensing
KLab can out-license its patented products
KLab can provide Oncology Formulations and API’s for the developing countries
Other Formulations
KLab can provide its formulations for marketing into the developing countries
Contract Manufacturing
KLab can provide Contract Manufacturing for Oncology and General products for the Developing Countries
KLab can sell its niche API’s for the developing countries.
KLab can provide Chiral Intermediates.

© 2001 - 2007 Khandelwal Laboratories Pvt.Ltd. All rights reserved.